Positron emission tomography in the diagnosis and staging of urinary bladder cancer

Acta Radiologica

Volumn 37, Issue 2, 1996, Pages 180-185

  Ahlstrom H ^a   Malmstrom P U ^a   Letocha, H ^a   Andersson, J ^a   Langstrom B ^a   Nilsson, S ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

MR; Urinary bladder neoplasm, emission CT

Indexed keywords

DEOXYGLUCOSE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORODEOXYGLUCOSE F 18; METHIONINE; METHIONINE METHYL ESTER;

AGED; ARTICLE; BLADDER TUMOR; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SCINTISCANNING;

AGED; AGED, 80 AND OVER; DEOXYGLUCOSE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; MIDDLE AGED; NEOPLASM STAGING; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER NEOPLASMS;

EID: 0030096160     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841859609173441     Document Type: Article

References (13)

1. HARNEY J. V., WAHL R. L., LIEBERT M. et al.: Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer. Animal localization and initial patient positron emission tomography. J. Urol. 145 (1991), 279.
2. HATAZAWA J., ISHIWATA K., ITOH M. et al.: Quantitative evaluation of L-(methyl-C-11)-methionine uptake in tumour using positron emission tomography. J. Nucl. Med. 30 (1989), 1809.
3. HUSBAND J. E. S., OLLIFF J. F. C., WILLIAMS M. P., HERON C. W. & CHERRYMAN G. R.: Bladder cancer. Staging with CT and MR imaging. Radiology 173 (1989), 435.
4. ITO K., KATO T., TADOKORO M. et al.: Recurrent rectal cancer and scar. Differentiation with PET and MR imaging. Radiology 182 (1992), 549.
5. KOPS E. R., HERZOG H., SCHMID A., HOLTE S. & FEINENDEGEN L. E.: Performance characteristics of an eight-ring whole body PET scanner. J. Comput. Assist. Tomogr. 14 (1990), 437.
6. 11C)methionine. J. Nucl. Med. 28 (1987), 1037.
7. LESKINEN-KALLIO S., HUOVINEN R., NÅGREN K. et al.: Methods of C-11-methionine quantitation in cancer PET studies. J. Comput. Assist. Tomogr. 16 (1992), 468.
8. 11C-methionine in the monitoring of therapy response in muscle-invasive transitional cell carcinoma of the urinary bladder. Br. J. Urol. 74 (1994), 767.
9. MALMSTRÖM P.-U., THORN M., LINDBLAD P., BERGSTRÖM R., KRUSEMO U.-B. & ADAMI H.-O.: Increasing survival in patients with urinary bladder cancer. A nation-wide study in Sweden 1960-1986. Eur. J. Cancer 29a (1993), 1868.
10. PATLAK C. S., BLASBERG R. G. & FENSTERMACHER J. D.: Graphic evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cerebr. Blood Flow Metab. 3 (1983), 1.
11. STRAUSS L. G. & CONTI P. S.: The applications of PET in clinical oncology. J. Nucl. Med. 32 (1991), 623.
12. TANIMOTO A., YUASA Y., YUTAKA I. et al.: Bladder tumour staging. Comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT. Radiology 185 (1992), 741.
13. UICC: TNM classification of malignant tumors. 3rd edition, Geneva 1978.